| Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system JE Schlosburg, JL Blankman, JZ Long, DK Nomura, B Pan, SG Kinsey, ... Nature neuroscience 13 (9), 1113-1119, 2010 | 686 | 2010 |
| Subcutaneous REGEN-COV antibody combination to prevent Covid-19 MP O’Brien, E Forleo-Neto, BJ Musser, F Isa, KC Chan, N Sarkar, KJ Bar, ... New England Journal of Medicine 385 (13), 1184-1195, 2021 | 452 | 2021 |
| Repeated Low-Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains Cannabinoid Receptor Type 1–Mediated Antinociceptive and Gastroprotective Effects SG Kinsey, LE Wise, D Ramesh, R Abdullah, DE Selley, BF Cravatt, ... Journal of Pharmacology and Experimental Therapeutics 345 (3), 492-501, 2013 | 174 | 2013 |
| Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability ZD Cooper, G Bedi, D Ramesh, R Balter, SD Comer, M Haney Neuropsychopharmacology 43 (10), 2046-2055, 2018 | 147 | 2018 |
| Blockade of endocannabinoid hydrolytic enzymes attenuates precipitated opioid withdrawal symptoms in mice D Ramesh, GR Ross, JE Schlosburg, RA Owens, RA Abdullah, SG Kinsey, ... Journal of Pharmacology and Experimental Therapeutics 339 (1), 173-185, 2011 | 122 | 2011 |
| Inhibitors of endocannabinoid-metabolizing enzymes reduce precipitated withdrawal responses in THC-dependent mice JE Schlosburg, BLA Carlson, D Ramesh, RA Abdullah, JZ Long, ... The AAPS journal 11, 342-352, 2009 | 121 | 2009 |
| Effect of subcutaneous casirivimab and imdevimab antibody combination vs placebo on development of symptomatic COVID-19 in early asymptomatic SARS-CoV-2 infection: a randomized … MP O’Brien, E Forleo-Neto, N Sarkar, F Isa, P Hou, KC Chan, BJ Musser, ... Jama 327 (5), 432-441, 2022 | 98 | 2022 |
| Utility of machine-learning approaches to identify behavioral markers for substance use disorders: impulsivity dimensions as predictors of current cocaine dependence WY Ahn, D Ramesh, FG Moeller, J Vassileva Frontiers in psychiatry 7, 34, 2016 | 92 | 2016 |
| Naltrexone maintenance decreases cannabis self-administration and subjective effects in daily cannabis smokers M Haney, D Ramesh, A Glass, M Pavlicova, G Bedi, ZD Cooper Neuropsychopharmacology 40 (11), 2489-2498, 2015 | 67 | 2015 |
| Marijuana’s dose-dependent effects in daily marijuana smokers. D Ramesh, M Haney, ZD Cooper Experimental and clinical psychopharmacology 21 (4), 287, 2013 | 66 | 2013 |
| Dual inhibition of endocannabinoid catabolic enzymes produces enhanced antiwithdrawal effects in morphine-dependent mice D Ramesh, TF Gamage, T Vanuytsel, RA Owens, RA Abdullah, ... Neuropsychopharmacology 38 (6), 1039-1049, 2013 | 63 | 2013 |
| Acute low back pain: differential somatosensory function and gene expression compared to healthy no-pain controls AR Starkweather, D Ramesh, DE Lyon, U Siangphorn, X Deng, J Sturgill, ... The Clinical journal of pain 32 (11), 933, 2016 | 56 | 2016 |
| Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users ES Herrmann, ZD Cooper, G Bedi, D Ramesh, SC Reed, SD Comer, ... Psychopharmacology 233, 2469-2478, 2016 | 56 | 2016 |
| Novel antibody cocktail targeting Bet v 1 rapidly and sustainably treats birch allergy symptoms in a Phase 1 study P Gevaert, J De Craemer, N De Ruyck, S Rottey, J de Hoon, PW Hellings, ... Journal of Allergy and Clinical Immunology 149 (1), 189-199, 2022 | 42 | 2022 |
| Prolonged Monoacylglycerol Lipase Blockade Causes Equivalent Cannabinoid Receptor Type 1 Receptor–Mediated Adaptations in Fatty Acid Amide Hydrolase Wild-Type and Knockout Mice JE Schlosburg, SG Kinsey, B Ignatowska-Jankowska, D Ramesh, ... Journal of Pharmacology and Experimental Therapeutics 350 (2), 196-204, 2014 | 42 | 2014 |
| Marijuana dependence: Not just smoke and mirrors D Ramesh, JE Schlosburg, JM Wiebelhaus, AH Lichtman ILAR Journal 52 (3), 295-308, 2011 | 40 | 2011 |
| Efficacy and safety of sarilumab in hospitalized patients with coronavirus disease 2019: a randomized clinical trial S Sivapalasingam, DJ Lederer, R Bhore, N Hajizadeh, G Criner, R Hosain, ... Clinical Infectious Diseases 75 (1), e380-e388, 2022 | 31 | 2022 |
| Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical Trial S Sivapalasingam, DJ Lederer, R Bhore, N Hajizadeh, G Criner, R Hosain, ... Clinical Infectious Diseases 75 (1), e380-e388, 2022 | 31 | 2022 |
| Contribution of endocannabinoid gene expression and genotype on low back pain susceptibility and chronicity D Ramesh, A D’Agata, A Starkweather, E Young The Clinical journal of pain 34 (1), 8, 2018 | 31 | 2018 |
| Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial GA Herman, MP O'Brien, E Forleo-Neto, N Sarkar, F Isa, P Hou, KC Chan, ... The Lancet Infectious Diseases 22 (10), 1444-1454, 2022 | 27 | 2022 |
Jonathan Z. LongAssistant Professor, Stanford UniversityVerified email at stanford.edu
